PROLANZA olanzapine 15mg tablet blister pack

Active ingredient:

olanzapine, Quantity: 15 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Olanzapine

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; hyprolose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; xanthan gum; polyvinyl alcohol; iron oxide black; lecithin; indigo carmine aluminium lake

Administration route:

Oral

Units in package:

21, 60, 30, 7, 14, 28, 40, 10, 50, 20

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Product summary:

Visual Identification: Light blue, oblong, biconvex film coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2011-08-11